Novartis AG

Novartis AG researches develops manufactures and markets healthcare products in Switzerland and internationally. The company operates through two segments: Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and physicians. It also provides cardiovascular ophthalmology neuroscience immunology hematology and solid tumor products. The Sandoz segment develops manufactures and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products including biosimilars; and biotechnology manufacturing services; and anti-infectives such as active pharmaceutical ingredients and intermediates primarily antibiotics. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop manufacture and commercialize inclisiran a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel Switzerland.